Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RT Nominal up8.170 +0.450 (+5.829%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Investment Properties248,619-7.587%281,564713,651733,218293,933
Property, plant, equip. & others8,493,098-2.281%8,036,8937,897,9047,394,9407,078,474
Land & other Lease Assets1,560,717-2.258%1,640,8721,686,3441,377,5361,648,191
Intangible Assets3,119,4551.911%3,123,3592,941,6911,856,6211,821,774
Interests in Asso. & JCEs1,590,863-1.804%11,835,18813,083,08414,814,22611,218,558
Other Non-current Assets26,061,3362.263%16,563,86912,340,94413,560,15810,332,481

41,074,0880.863%41,481,74538,663,61839,736,69932,393,411
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Inventories2,103,865-11.347%1,837,2972,018,4982,137,1321,731,596
Trade Receivables8,154,08064.147%7,215,5377,108,9704,947,8395,059,329
Cash & Bank Balances11,104,40216.039%8,549,47311,577,1897,768,2928,028,326
Other Current Assets12,457,97160.230%7,619,6896,272,61210,344,4988,994,067
Assets Held for Sale0--0000

33,820,31837.006%25,221,99626,977,26925,197,76123,813,318
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Trade Payables2,820,27788.337%2,183,4062,137,2132,676,4731,620,732
S-T Debt & Leases8,872,45116.278%8,511,89210,522,7404,118,2041,845,843
Other Current Liabilities13,157,88226.171%11,253,91414,205,4629,470,8308,018,917
Liab asso w/ Assets Held for Sale0--0000

24,850,61027.071%21,949,21226,865,41516,265,50711,485,492
Net Current Assets8,969,70874.888%3,272,784111,8548,932,25412,327,826
Total Assets Less Current Liabilities50,043,7969.143%44,754,52938,775,47248,668,95344,721,237
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
L-T Debt & Leases3,083,46048.233%1,164,6691,031,3407,898,82811,807,335
Other Non-current Liabilities1,182,62118.575%1,468,1781,285,3272,025,5151,804,830

4,266,08138.621%2,632,8472,316,6679,924,34313,612,165
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
  Share Capital413,680-0.170%414,384414,615414,942415,895
  Reserves32,959,8944.481%32,430,60029,574,68029,799,21324,159,728
  Others0--0000
Shareholders' Funds33,373,5744.420%32,844,98429,989,29530,214,15524,575,623
Non-controlling Interests12,404,14114.712%9,276,6986,469,5108,530,4556,533,449
Others0--0000

45,777,7157.022%42,121,68236,458,80538,744,61031,109,072
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/06
RMB(K¥)
2023/06
RMB(K¥)
2022/06
RMB(K¥)
2021/06
RMB(K¥)
Commitments------------
Contingent Liabilities------------
Remarks:  Real time quote last updated: 22/08/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,388,591
%Change12.311%
EPS / (LPS)RMB 0.188
NBV Per Share (¥)RMB 1.779
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.